took tirzepatide while pregnant i pregnancy recommendations Planning on GLP-1 Medications? Read This First! Are you trying to Tirzepatide and Pregnancy: Safety Facts – New warning about weight-loss drugs

In controlled research models, NNMT inhibition by 5-Amino-1MQ may increase intracellular NAD+ levels and SAM availability, making the compound relevant to investigations involving sirtuin activity, methylation capacity, and adipocyte differentiation

Normally NNMT tags nicotinamide using a methyl donor (SAM), which uses up NAD+ building blocks and methyl groups

The published data show that estrogen-like molecules can mimic or block endogenous estrogens biological effects through a series of non-genomic responses (Park et al., 2012

Mar 29 2012;366(13):1190-1199

Not Suitable For: The treatment is not suitable for: Pregnant or Breastfeeding Individuals: Due to potential risks to the foetus or breastfeeding infant

242 -cells primarily secrete somatostatin, which is an important regulatory hormone